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Background: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in
symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the
fast-track pathway may vary for different patient groups.
Methods: We examined data from 669 220 patients with 35 cancers diagnosed in 2006–2010 following either fast-track
or ‘routine’ primary-to-secondary care referrals using ‘Routes to Diagnosis’ data. We estimated the proportion of
fast-track referrals by sociodemographic characteristic and cancer site and used logistic regression to estimate
respective crude and adjusted odds ratios. We additionally explored whether sociodemographic associations varied
by cancer.
Results: There were large variations in the odds of fast-track referral by cancer (Po0.001). Patients with testicular and breast
cancer were most likely to have been diagnosed after a fast-track referral (adjusted odds ratios 2.73 and 2.35, respectively,
using rectal cancer as reference); whereas patients with brain cancer and leukaemias least likely (adjusted odds ratios
0.05 and 0.09, respectively, for brain cancer and acute myeloid leukaemia). There were sex, age and deprivation differences in
the odds of fast-track referral (Po0.013) that varied in their size and direction for patients with different cancers (Po0.001).
For example, fast-track referrals were least likely in younger women with endometrial cancer and in older men with testicular
cancer.
Conclusions: Fast-track referrals are less likely for cancers characterised by nonspecific presenting symptoms and patients
belonging to low cancer incidence demographic groups. Interventions beyond clinical guidelines for ‘alarm’ symptoms are
needed to improve diagnostic timeliness.
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Most patients with cancer first present with symptoms, typically to
a general practitioner (GP) in primary care (Elliss-Brookes et al,
2012). Reducing diagnostic delay in these patients by addressing
contributory patient and healthcare system factors is an important
goal for healthcare systems (Walter et al, 2012). In England,
dedicated referral pathways supported by national clinical guide-
lines have been in existence since 1999 to expedite referral for the
diagnostic evaluation of patients with suspected cancer in order to
reduce the length of diagnostic intervals after patients present to
their GPs (NICE, 2005). Patients judged to meet criteria for such
referrals are offered ‘urgent’ assessment by specialist hospital
services within 2 weeks. Hereafter, we use the term ‘fast-track’ to
denote referrals through this pathway, otherwise known as the
‘two-week-wait’ or ‘urgent’ referral pathway for suspected cancer.
Although diagnostic delays may occur both because of patient and
system factors (i.e., before and after presentation), in this paper we
focus on variation in the type of GP referral route, as a factor that
can affect the length of the post-presentation intervals.
Fast-track referral criteria are typically based on the presence of
‘alarm’ symptoms, although many cancer patients have no such
presenting symptoms (Stapley et al, 2012; Howell et al, 2013; Din
et al, 2015). Consequently, large proportions of patients with
cancer continue to be diagnosed through other diagnostic routes,
including following an emergency presentation, which is associated
with poorer survival (Elliss-Brookes et al, 2012; Abel et al, 2015).
Among cancer patients who are diagnosed after a GP referral,
nearly half are diagnosed after non-fast-track referrals (Elliss-
Brookes et al, 2012; NCIN, 2015). Despite a continual increase in
fast-track referral activity from 0.9 million to over 1.5 million
between 2009–2010 and 2014–2015 (NCIN, 2016), and evidence
suggestive of associations between higher general practice fast-
track referral activity and cancer survival (Møller et al, 2015), fewer
than half of all cancer patients are diagnosed through this route.
Therefore, considering how this proportion can be further
increased is important.
Previous research has examined practice-level variation in fast-
track referrals (Rogers et al, 2014; Maclean et al, 2015; Murchie
et al, 2015), but there is limited understanding of variation in the
type of primary–secondary care referrals between different patient
groups once a GP has decided to refer. Among patients who have
seen their doctor, understanding differences in the frequency of
fast-track and non-fast-track referrals can provide insights into
factors that influence decision making by GPs about the referral of
symptomatic patients, and enable the design and implementation
of targeted interventions to further increase the proportion of
cancer patients diagnosed who were fast-tracked. Such analyses can
also provide a ‘real-life’ evaluation of the effectiveness of healthcare
policies supporting fast-track referral pathways for suspected
cancer and identify the need for alternative strategies. We therefore
examined variation in referral type among patients whose
diagnosis involved either a fast-track or an elective GP referral,
to examine factors that might influence a GP’s decision to refer
through either of these routes.
MATERIALS AND METHODS
Data. Data were extracted from the National Cancer Data
Repository (NCDR) containing information on the diagnostic
‘route’ of all patients diagnosed with cancer in England during the
study period (2006–2010). ‘Diagnostic routes’ represent care
pathways to diagnosis. They are assigned using an algorithm
based on linked data from cancer registration, Hospital Episodes
Statistics, National Cancer Waiting Times and National Health
Service Cancer Screening Programmes (for breast, bowel and
cervical cancers) as previously described (Elliss-Brookes et al, 2012).
We only included patients who were diagnosed through a ‘two-
week wait’ and ‘non-two-week wait’ GP referral, excluding patients
diagnosed through any other diagnostic route (i.e., after screening,
elective hospitalisation, hospital outpatient appointment (other
than after a GP referral), emergency presentation, unknown route
or following death certification only). We did so because we were a
priori interested in factors that make the suspicion of cancer
diagnosis either harder or easier once patients have consulted with
a GP, outside of circumstances where an emergency hospital
referral is needed.
The ‘two-week wait’ route denotes diagnosis after an urgent GP
referral with a suspicion of cancer through the fast-track pathway,
whereas the non-two-week wait route represents elective GP
referrals that do not fit the fast-track criteria.
Available data included information on all patients with one of
35 categories of malignant neoplasms including anal, bladder,
breast, breast carcinoma in situ, colon, oral, oropharyngeal,
laryngeal, Hodgkin lymphoma, four types of leukaemia (acute
lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML),
chronic lymphocytic leukaemia (CLL) and chronic myeloid
leukaemia (CML)), liver, lung, malignant brain, melanoma,
mesothelioma, multiple myeloma, non-Hodgkin lymphoma, oeso-
phageal, ovarian, pancreatic, penile, prostate, rectal, renal, soft
tissue sarcoma, small intestine, stomach, testicular, thyroid,
uterine, vulval and cancer of unknown primary. Data were also
available on the patient’s age group, sex, year of diagnosis and
deprivation group based on national quintiles of the income
domain of the Index of Multiple Deprivation 2010 of the lower
super output area of the patients’ postcode of residence
(Department of Communities and Local Government, 2011).
Analysis
Main effect analysis. We examined the differences in crude
proportions of patients diagnosed through the fast-track route, by
cancer site, age, sex, deprivation group and year of diagnosis. The
choice of these variables reflects our hypothesis that among
patients who were diagnosed with cancer following a GP referral,
the use of fast-track referral varies by patient characteristic and
cancer site. Subsequently, we used logistic regression to estimate
odds ratios for fast-track route by variable category, first
unadjusted, then adjusted for age, sex, deprivation, year of
diagnosis and cancer site (for the latter, rectal cancer was used as
the reference category as a common cancer in either sex). Because
the adjusted odds ratios derived by the multivariate model do not
directly translate to the natural scale and to aid interpretation of
the findings, we additionally used the model output to estimate the
adjusted proportions of fast-tracked patients for each variable
group using the marginal standardisation method (Muller and
MacLehose, 2014).
Effect modification analysis. Because of prior evidence docu-
menting effect modification between patient characteristics and
cancer diagnosis in respect of other markers of diagnostic difficulty
(e.g., the number of pre-referral consultations and the proportion
of emergency presentations), we additionally examined interac-
tions between each of the three sociodemographic variables (age,
sex and deprivation) and cancer in respect of odds of fast-track
referrals (Lyratzopoulos et al, 2012; Abel et al, 2015). We added all
three interaction terms to the main effects model and retained
those that tested significant (Po0.001) using the joint Wald test.
RESULTS
There were 669 220 incident tumours contained within the
35 cancer sites diagnosed through either category of GP
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referrals between 2006 and 2010. Of these 339 500 (51%) were
diagnosed after fast-track and 329 720 (49%) after non-fast-track
referrals.
Hereafter, the patterns of variation described relate to cancer
patients diagnosed following a GP referral (either fast-track or
non-fast-track) only, and do not relate to ‘every’ patient in the
population with those cancers, excluding, for example, patients
diagnosed through screening, or after an emergency presentation
(see Data in Materials and Methods).
Main effects analysis. Considering unadjusted analyses, there was
very strong evidence (Po0.0001) for very large variation in the
proportions of fast-track referral by cancer site. This proportion
was highest (73 and 71%) for patients with breast and testicular
cancer, respectively, and lowest (6%) for patients with brain cancer.
In multivariable analysis, the results were largely concordant with
those of the unadjusted analysis. Patients subsequently diagnosed
with testicular and breast cancers were most likely to be diagnosed
through the fast-track pathway (OR 2.73, 95% CI 2.54–2.93
testicular vs rectal cancer, Table 1 and Figure 1A). Patients
subsequently diagnosed with brain cancer and any type of
leukaemia (AML, ALL, CLL, CML) were the least likely to be
referred through the fast-track route (OR 0.05, 95% CI 0.05–0.06,
Po0.0001; brain vs rectal cancer). The respective adjusted
proportions for patients with testicular and brain cancer were
77% and 6%. To appreciate the very large size of variation by
cancer site it should be noted that there is 450-fold variation in
the adjusted odds of fast-track referrals between testicular and
brain cancer, with a respective 12-fold variation in adjusted
proportions.
There was also very strong evidence (Po0.0001 for age, sex and
deprivation) of variation in the crude proportions of cancer
patients who were diagnosed after fast-track referral for patient
characteristics, although the size of sociodemographic variation,
where present, was relatively small compared with that observed
for cancer site. Specifically, there were moderate differences in the
proportion of fast-track referrals by age group and sex (Table 1),
for example, 47 vs 50% for 25–34/65–74 year olds and 46 vs 56%
for men/women. There was little variation in fast-track referral
proportions by deprivation group, with slightly lower proportions
of fast-track referrals in the highest and lowest quintiles. The
proportion of referred patients who were fast-tracked increased
during the 5-year study period from 48% in 2006 to 53% in 2010
(Po0.0001). In multivariable analysis, there was strong evidence
for variation by age group, with increasing odds of fast-track
referral up to age 84 years (Po0.0001, Table 1 and Figure 1B).
Although women had a higher chance of being fast-tracked than
men in the unadjusted analysis, a much smaller, and inverse,
association was found in adjusted analysis (OR 0.98, 95% CI 0.97–
1.00, P¼ 0.013). This observation reflects that breast cancer, that
has the highest proportion of fast-track referrals compared with all
cancers sites (73%), is far more common among women; once
cancer site is controlled for, this crude sex difference is adjusted
accordingly. The variation by deprivation group remained limited
in the unadjusted and adjusted analyses. The odds of fast-track
referrals were greater in 2010 compared with 2006 (adjusted OR
1.28, 95% CI 1.26–1.30, Po0.0001).
Effect modification. There was strong evidence for interactions
between cancer diagnosis and age, cancer diagnosis and sex, and
cancer diagnosis and deprivation (Figure 2A–C; Po0.0001 for all),
meaning that associations between patient characteristics and odds
of fast-track referral varied notably for patients with different
cancers (specific examples discussed in Box 1). The cancer-specific
variation was largest for age and much smaller for sex and
deprivation (Figure 2A–C).
DISCUSSION
We document large variations by cancer diagnosis and patient
characteristics in the proportion of patients who were diagnosed
after a fast-track primary-to-secondary care referral. Associations
of age, sex and deprivation varied in size and direction for patients
with different cancers.
Comparison with previous studies. Our findings amplify pre-
vious reports describing crude proportions of fast-track referral
pathways for patients with 15 and 38 cancers (Elliss-Brookes et al,
2012; NCIN, 2014), but the use of multivariable analysis allowed us
to estimate independent associations between fast-track referral
and cancer site, age, sex and deprivation group. These independent
associations are not subject to confounding by any of the attributes
included in the model. To illustrate the impact of confounding one
can consider that the highest unadjusted proportion of fast-track
referrals by age was observed in patients aged 35–54 years
(Table 1), reflecting that B40% of cancer patients of that age in
our analysis sample are women with breast cancer. However, after
adjustment for cancer site (and other variables) this pattern of
variation by age is lost. Furthermore, for the first time we report on
effect modification of patient characteristics by cancer site in
respect of the odds of fast-track referral. The increasing proportion
of patients diagnosed after a fast-track referral during the study
period suggests that the recently reported increase in ‘fast-track’
activity between 2010 and 2014 may have started during 2006–
2010 (Elliss-Brookes et al, 2012; NCIN, 2016). This trend could be
a reflection of the influence of healthcare interventions aimed at
improving cancer diagnosis, such as the introduction of clinical
guidelines for fast-track referrals for suspected cancer (NICE, 2005).
Strengths and limitations. We used data from a large population-
based sample that employed robust methodologies to assign
diagnostic route and included a wide range of cancers (Elliss-
Brookes et al, 2012). We did not have information on the general
practice and presence of co-morbidities of the referred patients,
and therefore in part our findings may be confounded by variation
between practices and patients (e.g., if practices with predomi-
nantly older patients have higher ‘fast-track’ referral rates, then the
age patterns that we report may be either overestimating or
underestimating the true variation by age). However, the reported
confidence intervals and P-values emanating from our regression
models are robust to potential overdispersion.
Although appropriately used in literature examining variations
in cancer processes and outcomes, odds ratios may lead to an
exaggerated perception of the size of differences in odds of fast-
track referrals between different patient groups. Although there is a
50-fold variation in the adjusted odds of a fast-track referral
between cancer sites, the corresponding variation in adjusted
proportions is 12-fold (see Table 1, ‘Adjusted proportions’
column). Nonetheless, this is still a very large difference by cancer
site in the proportion of patients diagnosed through a fast-track
referral.
We had no information on the diagnostic interval. However, it
can be assumed that referral intervals (from date of referral to date
seen at hospital) for most ‘routinely’ referred patient would be
longer by a few weeks compared with most patients who were
referred as ‘two-week wait’ referrals. Although our study only
examined post-presentation referral pathways, improvements
towards earlier diagnosis can also be achieved by shortening both
pre-presentation (mainly relating to patient factors) and post-
presentation intervals (patient and system factors) (Lyratzopoulos
et al, 2014, 2015).
Lastly, although we focus on patients who were referred through
the fast-track or elective route, approximately a fifth of all
emergency presentations (B3% of all incident cases) would occur
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Table 1. Observed and adjusted proportions of fast-track referrals, and crude and adjusted odds ratios for fast-track referrals by
cancer diagnosis, age, sex, year of diagnosis and deprivation group
Fast-track referrals
Variable category
Number of patients diagnosed
through GP referrals
N Observed (%)
Case-mix
adjusted (%)a
Crude odds
ratiosb
Adjusted odds
ratiosa,b
Cancer type
All cancers 669 220 339 500 50.7
Testicular 6096 4346 71.3 77.2 1.94 (1.81, 2.08) 2.73 (2.54, 2.93)
Breast 112 962 82 787 73.3 74.5 2.14 (2.08, 2.21) 2.35 (2.28, 2.42)
Oesophageal 18 324 11 793 64.4 63.6 1.41 (1.35, 1.47) 1.40 (1.34, 1.46)
Melanoma 37105 20 516 55.3 56.9 0.97 (0.93, 1.00) 1.06 (1.02, 1.09)
Oropharygeal 5291 2975 56.2 56.9 1.00 (0.94, 1.08) 1.05 (0.99, 1.13)
Rectal 35 452 19 906 56.1 55.6 Reference Reference
Oral 6078 3276 53.9 54.3 0.91 (0.85, 0.98) 0.95 (0.89, 1.01)
Lung 74553 39 533 53.0 52.2 0.88 (0.85, 0.91) 0.87 (0.85, 0.90)
Endometrial 24 431 12 656 51.8 51.6 0.84 (0.81, 0.87) 0.85 (0.82, 0.88)
Bladder 25 820 13 481 52.2 51.2 0.85 (0.82, 0.89) 0.84 (0.81, 0.87)
Stomach 13739 7163 52.1 51.3 0.85 (0.81, 0.89) 0.84 (0.80, 0.88)
Hodgkin lymphoma 4578 2030 44.3 50.2 0.62 (0.58, 0.67) 0.81 (0.75, 0.87)
Ovarian 13 918 6766 48.6 49.6 0.70 (0.66, 0.75) 0.79 (0.74, 0.83)
Breast in situ 7023 3330 47.4 49.6 0.74 (0.70, 0.77) 0.79 (0.75, 0.82)
Colon 46012 22 264 48.4 47.6 0.73 (0.71, 0.76) 0.72 (0.70, 0.75)
Vulval 3506 1597 45.6 46.0 0.65 (0.60, 0.71) 0.68 (0.63, 0.74)
Laryngeal 6522 2975 45.6 45.1 0.65 (0.61, 0.69) 0.66 (0.62, 0.70)
Anal 2822 1223 43.3 43.6 0.60 (0.54, 0.66) 0.62 (0.56, 0.67)
Mesothelioma 4742 2023 42.7 41.4 0.58 (0.54, 0.63) 0.56 (0.52, 0.60)
Renal 15 248 6268 41.1 40.9 0.55 (0.52, 0.57) 0.55 (0.53, 0.58)
Prostate 116164 47 037 40.5 39.1 0.53 (0.52, 0.55) 0.51 (0.50, 0.53)
Pancreatic 11 016 4160 37.8 37.0 0.47 (0.45, 0.50) 0.47 (0.44, 0.49)
Penile 1244 458 36.8 36.6 0.46 (0.40, 0.52) 0.46 (0.40, 0.53)
Non-Hodgkin lymphoma 25192 8864 35.2 35.3 0.42 (0.41, 0.44) 0.43 (0.42, 0.45)
Cancer of unknown primary 12 355 3829 31.0 30.8 0.35 (0.33, 0.37) 0.35 (0.34, 0.37)
Liver 4838 1352 27.9 27.4 0.30 (0.28, 0.33) 0.30 (0.28, 0.32)
Small intestine 1312 348 26.5 26.3 0.28 (0.24, 0.33) 0.28 (0.25, 0.33)
Multiple myeloma 8567 2251 26.3 25.7 0.28 (0.26, 0.30) 0.27 (0.26, 0.29)
Sarcoma 3607 822 22.8 23.7 0.23 (0.21, 0.25) 0.25 (0.22, 0.27)
Thyroid 6355 1267 19.9 22.6 0.19 (0.18, 0.21) 0.23 (0.21, 0.25)
CML 1133 246 21.7 22.5 0.22 (0.18, 0.26) 0.23 (0.20, 0.27)
CLL 6877 1440 20.9 20.4 0.21 (0.19, 0.22) 0.20 (0.19, 0.22)
ALL 399 48 12.0 14.7 0.11 (0.07, 0.15) 0.14 (0.10, 0.19)
AML 2800 293 10.5 10.3 0.09 (0.08, 0.11) 0.09 (0.08, 0.10)
Brain 3139 185 5.9 6.3 0.05 (0.04, 0.06) 0.05 (0.05, 0.06)
Age
0–24 4421 1666 37.7 40.2 0.62 (0.54, 0.70) 0.59 (0.54, 0.64)
25–34 11420 5361 46.9 40.3 0.90 (0.83, 0.97) 0.59 (0.56, 0.62)
35–44 34449 18 261 53.0 43.5 1.15 (1.10, 1.20) 0.68 (0.66, 0.71)
45–54 68321 36 402 53.3 47.4 1.16 (1.12, 1.20) 0.81 (0.79, 0.83)
55–64 134733 67 668 50.2 51.2 1.03 (1.00, 1.06) 0.96 (0.94, 0.98)
65–74 188210 93 298 49.6 52.2 Reference Reference
75–84 172467 88 726 51.4 52.6 1.08 (1.05, 1.11) 1.02 (1.00, 1.04)
85þ 55199 28 118 50.9 49.7 1.06 (1.02, 1.10) 0.90 (0.88, 0.92)
Sex
Men 346840 159 026 45.8 50.9 Reference Reference
Women 322380 180 474 56.0 50.5 1.50 (1.47, 1.53) 0.98 (0.97, 1.00)c
Year of diagnosis
2006 124593 59 746 48.0 47.7 Reference Reference
2007 128045 64 983 50.8 50.6 1.12 (1.08, 1.15) 1.14 (1.12, 1.16)
2008 134180 68 358 50.9 50.9 1.13 (1.09, 1.16) 1.15 (1.13, 1.17)
2009 139961 70 667 50.5 50.8 1.11 (1.07, 1.14) 1.14 (1.12, 1.17)
2010 142441 75 746 53.2 53.3 1.23 (1.20, 1.27) 1.28 (1.26, 1.30)
Deprivation quintile
1 (Least deprived) 133 976 66 688 49.8 50.0 Reference Reference
2 147422 75 604 51.3 51.4 1.06 (1.03, 1.09) 1.06 (1.04, 1.08)
3 143681 74 018 51.5 51.4 1.07 (1.04, 1.10) 1.07 (1.05, 1.08)
4 130559 66 611 51.0 50.9 1.05 (1.02, 1.08) 1.04 (1.02, 1.06)
5 (Most deprived) 113 582 56 579 49.8 49.7 1.00 (0.97, 1.03) 0.99 (0.97, 1.01)
Abbreviations: ALL¼ acute lymphoblastic leukaemia; AML¼ acute myeloid leukaemia; CLL¼ chronic lymphocytic leukaemia; CML¼ chronic myeloid leukaemia; GP¼general practitioner.
aEstimates derived from model including main effect terms for cancer site, age, sex, deprivation and year of diagnosis.
bPo0.0001 for all based on joint Wald test of categorical variables, except for sex.
cP¼ 0.0129 for adjusted odds ratios for sex.
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while the patient is awaiting to be seen following a referral to
hospital services (Murchie et al, 2017). Those patients form part of
about two-third of emergency presenters who have had at least one
prior relevant GP contact preceding their emergency presentation
(Abel et al, 2017; Murchie et al, 2017; Zhou et al, 2017). Our study
population relates to cancer patients who have been referred by
their GP. As such, the observed associations should not be taken to
relate to all patients who presented to a GP and were subsequently
diagnosed with cancer. Our study provides insights into GP
decision making regarding the use of different type of referrals
once a decision to refer has been made. A proportion of cancer
patients are diagnosed following a GP consultation who did not
result in either an urgent or elective referral; and our findings do
not extend to this group.
Interpretation and implications. In considering the implications
of the findings, we focus on patient groups at the extremes of the
spectrum of fast-track referral variation where inferences can be
more reliable, highlighting possible mechanisms for the observed
variation, and describing possible clinical, policy or research
implications. We consider two principal mechanisms that may
underlie the observed variation.
1. Symptom signature (variation by cancer in proportions of
patients with ‘alarm’ symptoms, and vice versa). Cancer patients
most likely to be fast-tracked include those with testicular, breast,
oesophageal, melanoma, oropharyngeal, oral and endometrial
cancer, where ‘alarm’ symptoms (such as testicular or breast
lumps, dysphagia, visible skin abnormalities, oral ulceration and
vaginal bleeding, respectively) are present in most patients at
presentation. Conversely, patients with cancers least likely to be
diagnosed after fast-track referrals encompass brain cancer, the
leukaemias and multiple myeloma, all characterised by presenting
with symptoms of low predictive value in most patients. For
example, approximately half of all patients with multiple myeloma
present with musculoskeletal/back pain, a common symptom with
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Figure 2. Cancer-specific odds ratios and associated 95% confidence
intervals for fast-track referrals, comparing: (A) 35–44 year olds with
65–74 year olds; (B) Women with men; (C) Most with least deprived.
ALL=acute lymphoblastic leukaemia; AML=acute myeloid leukaemia;
CLL=chronic lymphocytic leukaemia; CML=chronic myeloid leukaemia.
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Figure 1. Main effect variations in adjusted odds ratios of fast-track
referral. (A) Variation by cancer. (B) Variation by sociodemographic
characteristic. ALL=acute lymphoblastic leukaemia; AML=acute
myeloid leukaemia; CLL=chronic lymphocytic leukaemia; CML=chronic
myeloid leukaemia.
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low specificity for cancer in primary care (Hamilton and Kernick,
2007; Shephard et al, 2015). Similarly, most patients with brain
cancer and leukaemia, the two cancers dominated by high rates of
emergency presentations (Abel et al, 2015), either present as a
clinical emergency (such as a seizure or sepsis) or have vague
presenting symptoms that may limit the use of fast-track referral
pathways (Howell et al, 2013). For leukaemia, the availability of
primary care testing (e.g., full blood count) may often result in an
emergency admission through on-call haematology services,
negating the need (or even the opportunity) for fast-track referral.
The findings therefore further substantiate previous evidence
indicating that cancers with an obvious symptom signature (i.e.,
where most patients present with symptoms of high enough
predictive value) are more likely to be fast-tracked, and vice versa
(Lyratzopoulos et al, 2012, 2013).
2. Variation in the positive predictive values of symptoms
between patient subgroups with the same cancer. Between
patients with a given cancer, referral decisions seem to be
influenced by variation in the predictive value of potential
cancer symptoms in patients of different age and sex. This
can also be seen as a reflection of the variable incidence of
different cancers in patients of different demographic groups. For
example, women with endometrial cancer who are older than 55
years have a notably higher fast-track referral rate compared with
women under 55 years of age with the same cancer. A likely
explanation of this pattern is that vaginal bleeding has a high
predictive value for endometrial cancer in post-menopausal
women, but is not an alarm symptom for young women. Conversely,
testicular lump is likely to have higher predictive value for
testicular cancer in young as opposed to older men, and we see
that older patients with testicular cancer are much less likely
to be referred urgently (Figure 2A). Therefore, the cancer-
specific variations observed by age and sex likely reflect the
underlying risk of a person of a particular age and sex to have
that cancer.
Another example of the influence of variable predictive values of
given symptoms in patients of different sociodemographic groups
is provided by the variation by sex (women being less likely to have
been fast-track referred) for thyroid cancer: These patterns may at
least partly reflect the greater incidence of benign thyroid
conditions associated with a lump/palpable thyroid gland swelling,
including hypo- and hyperthyroidism in women compared with
men (Vanderpump, 2011)).
Age restrictions in the fast-track guidelines may explain some of
the cancer-specific variations by age for few cancers. For example,
we see an increase in fast-track rate for breast cancer and
endometrial cancer around the respective age thresholds for
referral (30 years for breast, and ‘post-menopausal’ for endome-
trial); however the influence of age-specific referral thresholds is
much less apparent for other cancers (Supplementary File 2). It is
worth noting the inherent relationship between age cutoffs used in
referral guidelines and the age-related PPV values per se. Fully
disentangling the effects of the two is challenging.
Additionally, we reflect on other patterns of variation that may
have clinical or policy implications but do not conform to the
above two principal aetiological explanations (Box 2).
Good ‘safety netting’ practices (CRUK, 2014; Nicholson et al,
2016), patient education and engagement in monitoring of
nonspecific symptoms, and clinical decision tools to assess risk
of multiple nonalarm symptoms may be useful in reducing
avoidable delays in cancers with difficult symptom signatures or
patients in low risk strata.
In conclusion, among patients who were diagnosed following a
GP referral, the use of fast-track referral varies substantially
between patients with different cancers and sociodemographic
characteristics. In particular, cancers with nonspecific symptoms
Box 1. Specific examples of cancer-specific variations by
age, sex and deprivation
Cancer-specific variation by age
Illustrating variability in the size of the age association, there was a much
steeper than average positive age gradient for women with endometrial
cancer, with the odds of fast-track referral for young women being
particularly small compared with older women with this cancer (OR
0.09, 95% CI 0.07–0.12, Po0.0001; 35–44 vs 65–74 year olds). Among
all women with endometrial cancer, thosep55 years old comprise 3318
out of 24 431 cases (14%) in our sample. At the other end of the
spectrum, decreasing odds of fast-track referral with increasing age were
observed for testicular cancer, with younger men having appreciably
higher odds of fast-track referral compared with older patients with this
cancer (OR 2.31, 95% CI 1.62–3.28, Po0.0001; 35–44 vs 65–74 year
olds, Figure 2A) – that is, a particularly steep negative age gradient. It
should be noted that among all men with testicular cancer in our sample,
those aged X65 years comprise 211 of 6096 cases (3%).
Given the size of the interaction between age and cancer, we further
estimated the odds of fast-track referrals by age group separately for each
of the 35 cancers (Supplementary File 1). By and large, four patterns of
associations can be distinguished.
1. An overall positive monotonic association (increasing age/increas-
ing odds): anal, breast, prostate and vulval cancers;
2. A slow-rising increase in odds until late middle age, subsequently
decreasing in older ages (an ‘n’ (or ‘inverse U’) shape pattern):
bladder, colon, lung, ovarian, rectal and stomach cancer (‘peak’ in
patients aged 55–64 years) and colon and rectal cancer (‘peak; in
the 65–74 years);
3. A ‘flat’ pattern where the odds of fast-track referral remain similar
across all age groups, acknowledging that in some cancers this
pattern may also partially reflect small number of cases and hence
very large confidence intervals around the estimate: for example,
oral, oropharyngeal cancer, sarcoma and non-Hodgkin lymphoma.
4. An inverse (negative) association of decreasing odds with
increasing age is observed: for example, testicular (see above), CLL.
Cancer-specific variation by sex
Within the overall pattern, women with thyroid cancer were
substantially less likely to be fast-tracked compared with men with the
same cancer (odds ratios 0.58, 95% CI 0.50–0.66, Po0.0001), whereas
women with breast cancer were substantially more likely to be fast-
tracked compared with men with breast cancer (odds ratios 1.82, 95% CI
1.60–2.06, Po0.0001).
Beyond the two cancers, there was also statistical evidence that women
had either higher or lower odds of fast-track referrals than men for
another 12 cancers (of the 28 that can occur in either sex), that is, for
small intestine, Hodgkin lymphoma, liver and renal cancer (higher) and
ALL, stomach, oral, oropharyngeal, mesothelioma, multiple myeloma,
laryngeal and rectal cancers (lower).
Cancer-specific variation by deprivation
Although the overall pattern of cancer-specific variation by deprivation
was small compared with that by age and sex, there was evidence that
patients of the most deprived group were more likely than those of the
least deprived group to be referred urgently with 4 cancers (small
intestinal, oral, vulval and breast), whereas most affluent patients were
more likely to be referred under the fast-track route with another 6
cancers (kidney, testicular, bladder, colon, melanoma and lung cancers).
There was relatively little variation in patients with the remaining 25
cancers. A similar pattern was seen for cancer-specific variation by
deprivation when comparing quintiles 1 and 3 (where the largest
difference in main effect size was seen) – there was no evidence for
difference between quintiles 1 and 3 for most cancer sites except for
endometrial and anal cancer (higher ORs of fast-track referral in quintile
3 compared with the least deprived group).
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and low-risk patients are less likely to have a fast-track referral.
We have highlighted two possible mechanisms that may explain
these variations, that is, variation by cancer in the proportion of
patients with typical ‘alarm’ symptoms supported by referral
guidelines; and in demographic groups with lower cancer risk.
Recently, the National Institute for Clinical Excellence (NICE) in
the United Kingdom has lowered cancer risk thresholds at which
fast-track referrals are recommended from 5 to 3%, although the
effects of this initiative are yet to be known (NICE, 2015). Our
findings provide the basis for further research to examine how GPs
make decisions in the diagnostic process, and motivate the
development, evaluation and implementation of strategies to
improve the timeliness of cancer diagnosis. These may include the
use of guidelines that enable referrals or investigations at lower
risk (possibly supported by clinical decision tools), the wider
availability of one-stop multi-specialty diagnostic clinics and safety
netting and patient activation interventions for particular cancer
groups.
ETHICS
This study used anonymised aggregated data from the Routes
to Diagnosis data set, available from the National Cancer
Registration and Analysis Service, Public Health England. Individual
patient consent and ethics clearance were therefore not required for
this study.
ACKNOWLEDGEMENTS
This project involves data derived from patient-level information
collected by the NHS, as part of the care and support of cancer
patients. The data are collated, maintained and quality assured by
the National Cancer Registration and Analysis Service, which is
part of Public Health England. YZ is a Wellcome Trust Primary
Care Clinician Doctoral Fellow, and was supported by an
Academic Clinical Fellowship in General Practice funded by
Health Education East of England for the duration of this work. GL
is supported by the Cancer Research UK Clinician Scientist
Fellowship award (C18081/A18180).
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
Abel GA, Mendonca SC, McPhail S, Zhou Y, Elliss-Brookes L, Lyratzopoulos
G (2017) Emergency diagnosis of cancer and previous general practice
consultations: insights from linked patient survey data. Br J Gen Pract
67(659): e377–e387.
Abel GA, Shelton J, Johnson S, Elliss-Brookes L, Lyratzopoulos G (2015)
Cancer-specific variation in emergency presentation by sex, age and
deprivation across 27 common and rarer cancers. Br J Cancer 112:
S129–S136.
CRUK (2014) Safety netting recommendations for primary care. Retrieved
from http://www.cancerresearchuk.org/health-professional/diagnosis/
suspected-cancer-referral-best-practice/safety-netting.
Department of Communities and Local Government (2011) English Indices of
Deprivation 2010. Retrieved from https://www.gov.uk/government/
statistics/english-indices-of-deprivation-2010.
Din NU, Ukoumunne OC, Rubin G, Hamilton W, Carter B, Stapley S,
Neal RD (2015) Age and gender variations in cancer diagnostic intervals
in 15 cancers: analysis of data from the UK Clinical Practice Research
Datalink. PLoS One 10(5): e0127717.
Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S,
Richards M (2012) Routes to diagnosis for cancer–determining the
patient journey using multiple routine data sets. Br J Cancer 107(8):
1220–1226.
Hamilton W, Kernick D (2007) Clinical features of primary brain tumours: a
case-control study using electronic primary care records. Br J Gen Pract
57(542): 695–699.
Howell DA, Smith AG, Jack A, Patmore R, Macleod U, Mironska E, Roman E
(2013) Time-to-diagnosis and symptoms of myeloma, lymphomas and
leukaemias: a report from the Haematological Malignancy Research
Network. BMC Hematol 13(1): 9.
Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP (2013) Measures of
promptness of cancer diagnosis in primary care: secondary analysis of
national audit data on patients with 18 common and rarer cancers. Br J
Cancer 108(3): 686–690.
Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA (2012) Variation
in number of general practitioner consultations before hospital referral for
cancer: findings from the 2010 National Cancer Patient Experience Survey
in England. Lancet Oncol 13(4): 353–365.
Lyratzopoulos G, Saunders C, Abel G, McPhail S, Neal R, Wardle J,
Rubin G (2015) The relative length of the patient and the primary care
interval in patients with 28 common and rarer cancers. Br J Cancer 112:
S35–S40.
Lyratzopoulos G, Saunders CL, Abel GA (2014) Are emergency diagnoses of
cancer avoidable? A proposed taxonomy to motivate study design and
support service improvement. Future Oncol 10(8): 1329–1333.
Maclean R, Jeffreys M, Ives A, Jones T, Verne J, Ben-Shlomo Y (2015) Primary
care characteristics and stage of cancer at diagnosis using data from the
national cancer registration service, quality outcomes framework and
general practice information. BMC Cancer 15(1): 500.
Møller H, Gildea C, Meechan D, Rubin G, Round T, Vedsted P (2015) Use of
the English urgent referral pathway for suspected cancer and mortality in
patients with cancer: cohort study. Br Med J 351: h5102.
Muller CJ, MacLehose RF (2014) Estimating predicted probabilities from
logistic regression: different methods correspond to different target
populations. Int J Epidemiol 43(3): 962–970.
Murchie P, Chowdhury A, Smith S, Campbell NC, Lee AJ, Linden D,
Burton CD (2015) General practice performance in referral for suspected
cancer: influence of number of cases and case-mix on publicly reported
data. Br J Cancer 112(11): 1791–1798.
Box 2. Other patterns of variation and likely
explanations
Very old age. In the oldest patients (above 85 year of age), a slight
reduction in the odds of fast-track referrals is observed (Po0.0001). This
may reflect preferences by patients and clinicians for fewer investigations
and ‘routine’ as opposed to fast-track referrals, or the presence of
physical or mental health comorbidity (including dementia) that may
impede symptom interpretation (NICE, 2015).
Bladder cancer. Although previous studies have shown that women with
bladder cancer are at increased risk of experiencing diagnostic delay
when compared with men (Elliss-Brookes et al, 2012; Rogers et al, 2014),
our findings indicate that doctors are equally likely to use fast-track
referral for men and women with that cancer. This seems to suggest that
the previously described inequalities by sex in the primary care interval
for patients with this cancer (Elliss-Brookes et al, 2012; Rogers et al,
2014) are likely to occur before a decision to refer is made (i.e., before
urological cancer is suspected).
Thyroid cancer and soft tissue sarcoma. Another group of cancers with
low fast-track referral proportions include thyroid and soft tissue
sarcoma that have obvious symptoms in many patients (i.e., abnormal
lump) that however have low specificity for cancer. We hypothesise that
most patients with thyroid or soft tissue lumps are referred routinely to
secondary care unless prior imaging reports exist that suggest otherwise.
Ensuring prompt primary care access to ultrasound imaging services
may improve initial pick-up rate, whereas the use of one-stop clinics
with specialist imaging and biopsy may reduce the overall diagnostic
interval for these cancers.
BRITISH JOURNAL OF CANCER Variation in GP referrals for suspected cancer
30 www.bjcancer.com |DOI:10.1038/bjc.2017.381
Murchie P, Smith SM, Yule MS, Adam R, Turner ME, Lee AJ, Fielding S
(2017) Does emergency presentation of cancer represent poor
performance in primary care? Insights from a novel analysis of linked
primary and secondary care data. Br J Cancer 116(9): 1148–1158.
NCIN (2014) Routes to diagnosis 2006-2010 workbook. Retrieved from
http://www.ncin.org.uk/publications/routes_to_diagnosis.
NCIN (2015) Routes to diagnosis 2006-2013 workbook. Retrieved from
http://www.ncin.org.uk/view?rid=3053.
NCIN (2016) Trends in Cancer Waiting Times metrics, England, 2009/10 to
2014/15. Retrieved from www.ncin.org.uk/view?rid=3101.
NICE (2005) Referral Guidelines for Suspected Cancer. Department of Health:
London.
NICE (2015) NICE guidelines [NG12]: Suspected cancer: recognition and
referral. Retrieved from http://www.nice.org.uk/guidance/NG12/.
Nicholson BD, Mant D, Bankhead C (2016) Can safety-netting improve
cancer detection in patients with vague symptoms? BMJ 355: i5515.
Rogers S, Gildea C, Meechan D, Baker R (2014) Access, continuity of care and
consultation quality: which best predicts urgent cancer referrals from
general practice? J Public Health 36(4): 658–666.
Shephard EA, Neal RD, Rose P, Walter FM, Litt EJ, Hamilton WT (2015)
Quantifying the risk of multiple myeloma from symptoms reported in
primary care patients: a large case–control study using electronic records.
Br J Gen Pract 65(631): e106–e113.
Stapley S, Peters TJ, Neal RD, Rose PW, Walter FM, Hamilton W (2012)
The risk of pancreatic cancer in symptomatic patients in primary care:
a large case–control study using electronic records. Br J Cancer 106(12):
1940–1944.
Vanderpump MP (2011) The epidemiology of thyroid disease. Br Med Bull
99(1): 39–51.
Walter F, Webster A, Scott S, Emery J (2012) The Andersen Model of Total
Patient Delay: a systematic review of its application in cancer diagnosis.
J Health Serv Res Policy 17(2): 110–118.
Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM,
Elliss-Brookes L (2017) Diagnosis of cancer as an emergency: a critical
review of current evidence. Nat Rev Clin Oncol 14: 45–56.
This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits
use, sharing, adaptation, distribution and reproduction in any
medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images
or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in a
credit line to the material. If material is not included in the article’s
Creative Commons license and your intended use is not permitted
by statutory regulation or exceeds the permitted use, you will need
to obtain permission directly from the copyright holder. To view a
copy of this license, visit http://creativecommons.org/licenses/by/
4.0/
r The Author(s) named above 2018
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)
Variation in GP referrals for suspected cancer BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2017.381 31
